Press Center

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2026 the firm is ranked among the TOP leading legal advisors in Russia. 

April 9^th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.

Active public discussions continue regarding the draft law “On the Foundations of State Regulation of Artificial Intelligence Technology Applications in the Russian Federation”, drafted by the Ministry of Digital Development of the Russian Federation. The document covers the development, implementation and use of artificial intelligence (hereinafter – “AI”), and establishes obligations for service owners, developers and users. Below is an overview of the key changes that will affect businesses.

On 24 March 2026, the State Duma adopted Bill No. 1136722-8 at its third reading, proposing to transfer the powers to review decisions of magistrates’ courts on cassation appeal from the cassation courts of general jurisdiction to the courts of the constituent entities of the Russian Federation. The initiative was put forward by the Supreme Court of the Russian Federation.

On 24 March 2025, the State Duma adopted, at the third reading, Draft Law No. 1097621-8 (the “Draft Law”), which prohibits employers from imposing a probationary period on women with children under the age of three.

As of March 1, 2026, the amendments introduced by Federal Law No. 168-FZ of June 24, 2025, to the Law of the Russian Federation "On Protection of Consumer Rights" have come into force.

Dmitry Kirillov, Partner at Lidings, will speak at the Conference "Tax Disputes and Key Trends in Judicial Practice" that will take place March 19–20 in Moscow.

The past days have been marked by landmark rulings from the Russian Supreme and Constitutional Courts, decisions that will influence future case law and the pharmaceutical market as a whole.